Free Trial

Organigram (OGI) Competitors

Organigram logo
C$1.85 -0.02 (-1.07%)
As of 08/1/2025 04:00 PM Eastern

OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJN

Should you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry.

Organigram vs. Its Competitors

Organigram (TSE:OGI) and CanniMed Therapeutics (TSE:CMED) are both small-cap cannabis companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

CanniMed Therapeutics has lower revenue, but higher earnings than Organigram.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OrganigramC$180.58M1.27-C$57.23M-C$0.47-3.91
CanniMed TherapeuticsN/AN/AN/AN/AN/A

In the previous week, Organigram had 1 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 1 mentions for Organigram and 0 mentions for CanniMed Therapeutics. Organigram's average media sentiment score of 0.00 equaled CanniMed Therapeutics'average media sentiment score.

Company Overall Sentiment
Organigram Neutral
CanniMed Therapeutics Neutral

8.4% of Organigram shares are owned by institutional investors. 31.3% of Organigram shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Organigram presently has a consensus price target of C$3.33, indicating a potential upside of 79.73%. Given Organigram's stronger consensus rating and higher possible upside, equities analysts plainly believe Organigram is more favorable than CanniMed Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Organigram
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
CanniMed Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -31.69%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.

Company Net Margins Return on Equity Return on Assets
Organigram-31.69% -17.59% -5.56%
CanniMed Therapeutics N/A N/A N/A

Summary

Organigram beats CanniMed Therapeutics on 7 of the 10 factors compared between the two stocks.

Get Organigram News Delivered to You Automatically

Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OGI vs. The Competition

MetricOrganigramDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$228.55MC$2.13BC$5.48BC$6.20B
Dividend YieldN/A2.92%4.73%6.72%
P/E Ratio-3.914.2628.8663.43
Price / Sales1.27677.32371.451,250.99
Price / Cash3.8510.3535.4583.29
Price / Book0.6510.838.264.86
Net Income-C$57.23MC$21.15BC$3.25BC$301.20M
7 Day Performance-10.63%0.35%-3.75%-2.27%
1 Month Performance-2.63%4.46%4.27%0.79%
1 Year Performance-9.76%2.65%25.85%26.62%

Organigram Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OGI
Organigram
2.3544 of 5 stars
C$1.85
-1.1%
C$3.33
+79.7%
-15.9%C$228.55MC$180.58M-3.91987
CMED
CanniMed Therapeutics
N/AN/AN/AN/AC$668.44MN/A0.00147,000
WEED
Canopy Growth
1.7644 of 5 stars
C$1.54
+3.4%
C$2.20
+42.9%
-84.5%C$247.74MC$519.68M-0.222,700
EMC
Emblem
N/A$1.88
+1.6%
N/A+0.0%$245.45M$5.71M-9.89N/A
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150
MGW
Maple Leaf Green World
N/AC$0.79
+777.8%
N/A+0.0%C$111.69MN/A0.00N/AGap Up
BE
Beleave
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
BLO
Cannabix Technologies
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
SL
Supreme Cannabis Company Inc,
N/AN/AN/AN/AC$0.00N/A0.00N/AGap Down
High Trading Volume
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/A0.007,600

Related Companies and Tools


This page (TSE:OGI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners